Role of DAT‐SPECT in the diagnostic work up of Parkinsonism
- 7 May 2007
- journal article
- review article
- Published by Wiley in Movement Disorders
- Vol. 22 (9), 1229-1238
- https://doi.org/10.1002/mds.21505
Abstract
The diagnosis of idiopathic Parkinson's disease (PD) can be achieved with high degrees of accuracy in cases with full expression of classical clinical features. However, diagnostic uncertainty remains in early disease with subtle or ambiguous signs. Functional imaging has been suggested to increase the diagnostic yield in parkinsonian syndromes with uncertain clinical classification. Loss of striatal dopamine nerve terminal function, a hallmark of neurodegenerative Parkinsonism, is strongly related to decreases of dopamine transporter (DAT) density, which can be measured by single photon emission computed tomography (SPECT). The use of DAT‐SPECT facilitates the differential diagnosis in patients with isolated tremor symptoms not fulfilling PD or essential tremor criteria, drug‐induced, psychogenic and vascular Parkinsonism as well as dementia when associated with Parkinsonism. This review addresses the value of DAT‐SPECT in early differential diagnosis, and its potential as a screening tool for subjects at risk of developing PD as well as issues around the assessment of disease progression. © 2007 Movement Disorder SocietyKeywords
This publication has 97 references indexed in Scilit:
- What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?Brain, 2006
- Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patientsJournal of Neural Transmission, 2004
- N-Terminal Phosphorylation of the Dopamine Transporter Is Required for Amphetamine-Induced EffluxPLoS Biology, 2004
- Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosisMovement Disorders, 2004
- 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsyNeurological Sciences, 2003
- [ 123 I]β-CIT and SPECT in essential tremor and Parkinson's diseaseJournal of Neural Transmission, 1998
- Regional dopamine transporter gene expression in the substantia nigra from control and Parkinson's disease brainsJournal of Neurology, Neurosurgery & Psychiatry, 1998
- ?-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivoJournal of Neural Transmission, 1995
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984